Control of cardiovascular risk factors in patients with stroke attended in primary care in Spain. ICTUSCARE study;Control de los factores de riesgo cardiovascular en pacientes con ictus atendidos en Atención Primaria en España. Estudio ICTUSCARE

Medicina Clinica

Volumn 136, Issue 8, 2011, Pages 329-335

  Abellán Alemán, José ^a   Ruilope Urioste, Luis Miguel ^a   Leal Hernández, Mariano ^a   Armario García, Pedro ^a   Tiberio López, Gregorio ^a   Martell Claros, Nieves ^a  

^a CATHOLIC UNIVERSITY OF MURCIA   (Spain)

Author keywords

Cardiovascular risk factor; control; Primary Care; Stroke

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; THIAZIDE DIURETIC AGENT; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE CONTROL; DYSLIPIDEMIA; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIMARY MEDICAL CARE; RISK FACTOR; SPAIN;

AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PRIMARY HEALTH CARE; RISK FACTORS; SPAIN; STROKE;

EID: 79952817448     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.04.035     Document Type: Article

References (27)

1. Balmaceda R, León-Carrión J, Barroso-Martín JM. Epidemiología del trastorno cerebrovascular. Revista Española de Neuropsicología. 2003;3-4:251-66.
2. Abadal LT, Puig T, Balaguer Vintró I. Incidence, mortality and risk factors for stroke in the Manresa Study: 28 years of follow-up. Rev Esp Cardiol. 2000;53:13-4.
3. Marrugat J, Arboix A, García-Eroles L, Salas T, Vila J, Castell C, et al. The estimated incidence and case fatality rate of ischemic and hemorrhagic cerebrovascular disease in 2002 in Catalonia. Rev Esp Cardiol. 2007;60:575-80.
4. González-Juanatey JR, Mazón P, Soria F, Barrios V, Rodríguez L, Bertomeu V. Actualización (2003) de las Guías de Práctica Clínica de la Sociedad Española de Cardiología en hipertensión arterial. Rev Esp Cardiol. 2003;56:487-97.
5. JNC 7 Express. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. U.S. Department of Health and Human Services National Institutes of Health, National Heart, Lung, and Blood Institute. NIH Publication No.03-5233. December 2003.
6. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32:2735-40. (Pubitemid 33134456)
7. Sanclemente C, Alonso F, Rovira E, Vigil D, Vilaró P. Accidentes vasculares cerebrales en la comarca de Osona: factores de riesgo cardiovascular. An Med Interna. 2004;21:9-17.
8. Acha O, Hernández Jl, Penado S, Cano M, Riancho JA. Factores de riesgo e ictus en pacientes de diferentes edades. Rev Clin Esp. 2003;203:189-92. (Pubitemid 36656554)
9. Kirshner HS. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician role. Int J of Clin Pract. 2007;61:1739-48. (Pubitemid 47407735)
10. Leoo T, Lindgren A, Petersson J, von Arbin M. Risk factors and treatment at recurrent stroke onset: results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study. Cerebrovasc Dis. 2008;25:254-60. (Pubitemid 351450429)
11. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke. 2006;37:577-617.
12. Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366:29-36. (Pubitemid 40956527)
13. Arboix A, García-Eroles L, Comes E, Oliveres M, Targa C, Balcells M, et al. Importance of cardiovascular risk profile for in-hospital mortality due to cerebral infarction. Rev Esp Cardiol. 2008;61:1020-9.
14. Alvarez-Sabin J, Quintana M, Hernandez-Presa MA, Alvarez C, Chaves J, Ribo M. Therapeutic interventions and success in risk factor control for secondary prevention of stroke. J Stroke Cerebrovasc Dis. 2009;18:460-5.
15. Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, et al. Risk assessment for a first stroke in Spanish hypertensive population in primary care. The ERIC-HTA study. Med Clin (Barc). 2005;125:247-51.
16. Rigau D, Álvarez-Sabin J, Gil A, Abilleira S, Borras F, Armario P, et al. Guía de práctica clínica sobre prevención primaria y secundaria del ictus. Med Clin (Barc). 2009;133:754-62.
17. Gil-Núñez A, Vivancos J, Gabriel R. Diagnóstico y prevención secundaria del infarto cerebral en España. Estudio DIAPRESIC. Med Clin (Barc). 2008;131:765-9.
18. Del Saz P, Maestre JF, Arenillas JF. Ateromatosis intracraneal. Med Clin (Barc). 2008;131:141-52.
19. Scharader J, Luders S, Kulscherwski A, Hammersen F, Plate K, Berger J, et al. Morbidity and mortality after stroke. Eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke. 2005;36:1218-26.
20. Dahlöf B, Devereux RB, Kjedkdsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan intervention for end point reduction in hypertensive study (LIFE): a randomized trial against atenolol. Lancet. 2002;359:995-1003. (Pubitemid 34286536)
21. Tobaruela M, Rausell VJ, Sanz JA, Azorín MD, Abellán J, Hallal H. Prescripción de antihipertensivos en Atención Primaria y Especializada. Hipertensión. 2002;19 Suppl 2:169-70.
22. Rausell VJ, Tobaruela M, Sanz JA, López-Picazo J, Sánchez JF, Abellán J. Utilización de antihipertensivos en Atención Primaria. Hipertensión. 2003;20:96-104.
23. Coca A. Evolución del control de la hipertensión arterial en Atención Primaria en España. Resultados del estudio Controlpres 2003. Hipertensión. 2005;22:5-14.
24. Bramlage P, Thoenes M, Kirch W, Lenfant C. Clinical practice and recent recommendations in hypertension management-reporting a gap in a global survey of 1259 primary care physicians in 17 countries. Curr Med Res and Opin. 2007;23:783-91. (Pubitemid 46631482)
25. Marcosa G, Robles NR, Barroso S, Sánchez JF, por los investigadores participantes en el estudio COFRE Control de la dislipemia y uso de hipolipemiantes en Extremadura: resultados del estudio de Control de Factores de Riesgo de Extremadura (Estudio COFRE). Clin Invest Arterioscl. 2009;21:56-61.
26. Coca A, Dalfo A, Esmaties E, Llisterri JL, Ordóñez J, Gomis R. Tratamiento y control del riesqo cardiovascular en atención primaria en España. Estudio PREVENCAT. Med Clin (Barc). 2006;265:201-5.
27. Callea H, Costab A, Diez-Espino J, Franch J, Godoy A. Evaluación del cumplimiento de los objetivos de control metabólico de la diabetes mellitus tipo 2. Estudio TranSTAR. Med Clin (Barc). 2003;120:446-50.